Cannabis Stock Gainers And Losers From September 24, 2024
NASDAQ-Listed Aurora Cannabis Breaks Up With Uruguay: It's Not You, It's The Market
Aurora Cannabis Leadership Shift to Boost Global Growth
Aurora Cannabis Appoints CEO Martin as Executive Chair
Aurora Cannabis Brief: Outgoing Chairman Ron Funk Appointed Lead Independent Director, as Part of Board Leadership Transition
Aurora CEO Miguel Martin Takes on Additional Role as Executive Chairman of Board of Directors
Press Release: Aurora CEO Miguel Martin Takes on Additional Role as Executive Chairman of Board of Directors
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes
Aurora's CBD Lozenge Partnership: Here's Where To Find The New Product
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Aurora Cannabis Launches New CBD Lozenge in Canada, Developed With Vectura Fertin Pharma
Daily Option Recap | Nvidia rebounded before the market, one call option was thrown out with a bid of $20 million for bullish; Tesla fell more than 8% last Friday, multiple end-of-the-world put options made over 20 times profit.
The day before the iPhone 16 launch event, Apple's implied volatility rose to 58.71%; after the non-farm payroll release, EEM options trading became active, with differences between long and short positions among large traders.
Cannabis Stock Movers For September 6, 2024
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
American Views on Marijuana Effects Worsening: Gallup
Shares of Cannabis Stocks Are Trading Lower After the DEA Announced a Delay on Its Final Ruling on Cannabis Rescheduling Until After the November Presidential Election.
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
The hearing on the reclassification of cannabis is approaching, and both US cannabis stocks and ETFs are under pressure.
The upcoming open hearing on December 2nd by the US Drug Enforcement Administration has attracted widespread attention from the market, and aims to discuss the proposal to reclassify marijuana.
DEA Sets Hearing on Cannabis Rescheduling and Delays Decision Until After the Election